Only 1 in 100 people with lighter skin tones have melanonychia, but 70 in 100 with darker skin tones have it
Because this analysis included only patients who completed 36 weeks of treatment, discontinuations due to adverse events or dose-limiting intolerance were not systematically captured
The difference is rarely the formula
Reimbursement and formulary status for GLP-1 RAs depend on: clinical endpoints (A1c and weight loss thresholds), tolerability and discontinuation rates, and increasingly, cardiometabolic outcomes
Furthermore, publicly available references demonstrated that the majority of these taxa were also found in different body sites of humans
If you are experiencing symptoms or managing a chronic condition, a personalized Root Cause Analysis with a functional nutritionist is the right next step